We use cookies to help us improve the website and your experience using it. You may delete and block all cookies from this site at any time. However, please note this may result in parts of the site no longer working correctly. If you continue without changing your settings we will assume you are happy to receive all cookies on this site.


Core-Binding Factor (CBF) Leukaemias

Paired PB and BM samples are required for MRD as per the specimen requirements table.

Use of DLI or monitoring patients pre and post-transplant can be very informative for their clinical management. A repeat sample should always be tested if a significant change in transcript levels is observed to confirm this change, prior to any alteration in therapeutic decision making, which applies to all MRD monitoring.